Investors weighing digital-asset and technology infrastructure exposure often find themselves comparing names that share a crypto lineage but occupy very different competitive positions. BKKT (Bakkt Holdings) and CORZ (Core Scientific) offer a useful case study: both were born from the cryptocurrency economy, yet one is pivoting toward regulated payments and stablecoin infrastructure while the other is converting its power-and-real-estate footprint into AI data-center capacity. This stock comparison is most relevant to growth and momentum-oriented traders, as well as investors assessing relative performance, market positioning, and the durability of each company's catalysts. I also checked this using Tickeron’s AI Screener to see how the stock compares to others in the industry.
Bakkt Holdings operates a regulated fintech platform providing crypto trading, custody, stablecoin payments, and cross-border settlement infrastructure to institutions and businesses. In recent weeks, sentiment around BKKT has been shaped by a mixed earnings picture. The company reported a quarterly net profit of roughly $14 million, but that figure was largely driven by a $26.8 million non-cash gain on warrants rather than operating performance. Stripping out that item, the business posted an operating loss and negative adjusted EBITDA, while total revenue declined roughly 63% year over year, reflecting lower cryptocurrency trading activity.
Bakkt has set ambitious targets of approximately $3 billion in total transacting volume (TTV) for 2026 and $6 billion for the first half of 2027, but reported quarterly TTV has remained well below the pace those goals imply. Cash reserves have also declined, and the stock continues to exhibit elevated volatility and weak technical signals. The near-term investment case rests heavily on client activations and the launch of a cross-border institutional trading desk.
Core Scientific is transforming from one of North America's largest Bitcoin miners into a high-density data-center colocation provider for artificial intelligence and high-performance computing customers. The company has secured multi-year contracts with major tenants, including CoreWeave and AMD (Advanced Micro Devices), and is exiting Bitcoin mining by year-end to become a pure-play infrastructure operator. In its latest quarter, CORZ reported total revenue of roughly $232.9 million, up about 187% year over year, with colocation revenue of $215.4 million representing the vast majority of sales.
Adjusted EBITDA more than tripled sequentially to approximately $133.6 million, with margins expanding toward 57%. Management has outlined a contracted portfolio exceeding $24 billion in total revenue and roughly $1.8 billion in average annualized recurring revenue once fully delivered. However, the pivot carries execution risk: heavy capital expenditure, meaningful debt, and reliance on a small number of large tenants. Despite strong operating results, shares have faced near-term selling pressure as the broader AI-infrastructure trade has cooled. From what I see, the revenue quality here stands out.
The contrast between these two stocks is fundamentally about revenue quality and growth drivers. CORZ is converting physical assets into predictable, contracted colocation revenue with expanding margins, but it carries substantial debt and concentration risk tied to a handful of hyperscale tenants. BKKT is a smaller, higher-beta company whose recent "profit" was an accounting artifact, and whose future depends on an unproven step-change in transaction volume.
On sector exposure, Core Scientific is now effectively an AI-infrastructure play, while Bakkt remains a crypto-and-payments infrastructure story sensitive to trading sentiment. On momentum, Core Scientific shows fundamental improvement that has not always been reflected in price action, whereas Bakkt's technical profile has remained weak despite periodic sector-driven rallies. The trade-off for investors is stability and scale versus speculative optionality. I’m watching this closely as the data centers scale.
Based on observable factors such as trend consistency, revenue visibility, and the quality of earnings, Tickeron's AI currently favors CORZ over BKKT. Core Scientific's shift to multi-year, contracted colocation revenue and its rapidly expanding adjusted EBITDA provide a more stable, higher-quality growth foundation than Bakkt's reliance on future volume acceleration that has yet to materialize. Bakkt's optionality could re-rate if its institutional volume ramp succeeds, but on present data its technicals and operating losses weigh on the outlook. The verdict is therefore probabilistic rather than definitive: CORZ ranks as the stronger relative choice in this comparison.
In my research process, I frequently review Tickeron’s AI Trading Bots to understand how automated strategies align with current market conditions across different timeframes and risk profiles. This helps me cross-check the relative positioning of names like these two without relying solely on manual analysis.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
BKKT saw its Moving Average Convergence Divergence Histogram (MACD) turn negative on November 12, 2026. This is a bearish signal that suggests the stock could decline going forward. Tickeron's A.I.dvisor looked at 50 instances where the indicator turned negative. In 46 of the 50 cases the stock moved lower in the days that followed. This puts the odds of a downward move at 90%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where BKKT declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 90%.
The Aroon Indicator for BKKT entered a downward trend on November 19, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The RSI Indicator shows that the ticker has stayed in the oversold zone for 6 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an Uptrend is expected.
The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 6 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.
Following a +11.51% 3-day Advance, the price is estimated to grow further. Considering data from situations where BKKT advanced for three days, in 183 of 216 cases, the price rose further within the following month. The odds of a continued upward trend are 85%.
BKKT may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
The Tickeron PE Growth Rating for this company is 11 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Valuation Rating of 27 (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.547) is normal, around the industry mean (16.188). P/E Ratio (-0.738) is within average values for comparable stocks, (45.064). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (3.648). Dividend Yield (0.000) settles around the average of (0.427) among similar stocks. P/S Ratio (0.170) is also within normal values, averaging (103.301).
The Tickeron SMR rating for this company is 94 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Price Growth Rating for this company is 95 (best 1 - 100 worst), indicating slightly worse than average price growth. BKKT’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. BKKT’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 92, placing this stock worse than average.
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
Industry ComputerCommunications